2020
DOI: 10.1080/15548627.2020.1714209
|View full text |Cite
|
Sign up to set email alerts
|

Autophagy-dependent ferroptosis drives tumor-associated macrophage polarization via release and uptake of oncogenic KRAS protein

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
314
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 416 publications
(315 citation statements)
references
References 88 publications
0
314
0
1
Order By: Relevance
“…For example, ferroptotic cancer cells release oncogenic KRAS protein which can be engulfed and drive tumor-associated macrophage polarization. 112 Ferroptosis also occurs in macrophages. [113][114][115] However, compared with cancer cells, macrophages exert higher resistance to ferroptosis.…”
Section: The Interaction Of Ferroptosis and Lipid Metabolism Modulatementioning
confidence: 99%
“…For example, ferroptotic cancer cells release oncogenic KRAS protein which can be engulfed and drive tumor-associated macrophage polarization. 112 Ferroptosis also occurs in macrophages. [113][114][115] However, compared with cancer cells, macrophages exert higher resistance to ferroptosis.…”
Section: The Interaction Of Ferroptosis and Lipid Metabolism Modulatementioning
confidence: 99%
“…Two major subtypes of tumor-associated macrophages (TAMs) are generated depending on different environmental stresses, including antitumor M1 and procarcinogenic M2 TAMs (111). The KRAS G12D protein released from ferroptotic pancreatic cancer cells is further absorbed by macrophages through an advanced glycosylation end product-specific receptor, which then induces STAT3-dependent fatty acid oxidation and drives macrophages to form M2-like TAMs (112). Oxidized phosphatidylcholine from ferroptotic cancer cells also inhibits DC maturation and inhibits the differentiation of T helper 17 (TH17) cells through activation of NRF2 (113).…”
Section: Ferroptosis In Tumor Microenvironments and Immunotherapy Ofmentioning
confidence: 99%
“…Biochemically, ferroptosis can be suppressed by various small molecules, involving iron chelators (e.g., deferoxamine), lipophilic antioxidants (e.g., α -tocopherol), and lipid peroxidation inhibitors [ 21 24 ] that to the maximum extent do not similar with other forms of RCD [ 1 , 5 , 25 , 26 ]. Moreover, while numerous genes including p53 [ 7 , 27 , 28 ], nuclear factor E2-related factor 2 ( Nrf2 ) [ 29 , 30 ], and autophagy-related ( ATG ) genes [ 9 , 31 ] modulate different RCDs, a distinct set of genes such as ribosomal protein L8 ( RPL8 ), ATP synthase F0 complex subunit C3 ( ATP5G3 ), tetratricopeptide repeat domain 35 ( TTC35 ), citrate synthase, and iron response element binding protein 2 ( IREB2 ) seems peculiar to regulate ferroptosis [ 1 ]. As ferroptosis shares different mechanisms with other forms of cell death, it could unquestionably circumvent their limitations.…”
Section: Main Textmentioning
confidence: 99%